Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SUMO2 anticorps

L’anticorps Souris Monoclonal anti-SUMO2 a été validé pour WB, IHC, IF, FACS et StM. Il convient pour détecter SUMO2 dans des échantillons de Humain.
N° du produit ABIN6940601

Aperçu rapide pour SUMO2 anticorps (ABIN6940601)

Antigène

Voir toutes SUMO2 Anticorps
SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

Reactivité

  • 101
  • 40
  • 36
  • 3
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 80
  • 25
  • 1
Souris

Clonalité

  • 81
  • 26
Monoclonal

Conjugué

  • 57
  • 9
  • 8
  • 7
  • 5
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SUMO2 est non-conjugé

Application

  • 70
  • 53
  • 37
  • 21
  • 13
  • 11
  • 11
  • 9
  • 6
  • 5
  • 4
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Staining Methods (StM)

Clone

SM23-496
  • Specificité

    This MAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer's disease.

    Réactivité croisée (Details)

    Predicted to show a broad species reactivity.

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant human SUMO2 protein

    Isotype

    IgG1 kappa
  • Indications d'application

    Positive Control: MCF-7, HepG2, HeLa cells. Breast carcinoma.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))

    Autre désignation

    SUMO2 & SUMO3

    Poids moléculaire

    11-13kDa

    ID gène

    6613, 6612

    UniProt

    P61956, P55854

    Pathways

    Methionine Biosynthetic Process
Vous êtes ici:
Chat with us!